GlobeNewswire Inc | Nov 8, 2021 08:00AM EST

November 08, 2021

CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell and genome engineering company, today announced that Robert Ang, M.B.B.S., MBA, Vors President and Chief Executive Officer, and Nathan Jorgensen, Ph.D., Vors Chief Financial Officer, will be participating in two upcoming virtual investor conferences:

Stifel 2021 Virtual Healthcare ConferenceFireside Chat Date: Monday, November 15, 2021Time: 4:00 PM ET

Evercore ISI 4th Annual HealthCONx Virtual ConferenceFireside Chat Date: Thursday, December 2, 2021Time: 10:55 AM ET

A live webcast of both fireside chats can be accessed via the Investors section of the Company's website at www.vorbio.com. An archived replay of each webcast will also be available.

About Vor BiopharmaVor Biopharma is a clinical-stage cell and genome engineering company that aims to change the standard of care for patients with blood cancers by engineering hematopoietic stem cells to enable targeted therapies post-transplant. For more information, visit:www.vorbio.com.

Contacts:

Investors:Chris BrinzeyICR Westwicke +1 339-970-2843chris.brinzey@westwicke.com

Media:Sarah Spencer+1 857-242-6076sspencer@vorbio.com